Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
O'Donnell
Peter H
PH
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Artz
Andrew S
AS
Undevia
Samir D
SD
Pai
Rish K
RK
Del Cerro
Paula
P
Horowitz
Sarah
S
Godley
Lucy A
LA
Hart
John
J
Innocenti
Federico
F
Larson
Richard A
RA
Odenike
Olatoyosi M
OM
Stock
Wendy
W
Van Besien
Koen
K